Sophocarpidine (CAS-519-02-8) Market Report

Global Sophocarpidine (CAS-519-02-8) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：190
  • REPORT CODE：GMM863026
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

    Sophocarpidine (CAS-519-02-8) market report explains the definition, types, applications, major countries, and major players of the Sophocarpidine (CAS-519-02-8) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Indena

    • TIANSHAN Pharmaceuticals

    • QHL Pharma

    • Tiansheng Pharmaceutical

    • Fujie Pharmaceutical

    • Jiangsu Tiansheng Pharmaceutical

    • Select Botanical

    • Selco Wirkstoffe Vertriebs GmbH

    • Qinghai Lake Pharmaceuticals

    By Type:

    • High Purity

    • Low Purity

    By End-User:

    • Pharmaceuticals

    • Pesticides

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Sophocarpidine (CAS-519-02-8) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Sophocarpidine (CAS-519-02-8) Outlook to 2028- Original Forecasts

    • 2.2 Sophocarpidine (CAS-519-02-8) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Sophocarpidine (CAS-519-02-8) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Sophocarpidine (CAS-519-02-8) Market- Recent Developments

    • 6.1 Sophocarpidine (CAS-519-02-8) Market News and Developments

    • 6.2 Sophocarpidine (CAS-519-02-8) Market Deals Landscape

    7 Sophocarpidine (CAS-519-02-8) Raw Materials and Cost Structure Analysis

    • 7.1 Sophocarpidine (CAS-519-02-8) Key Raw Materials

    • 7.2 Sophocarpidine (CAS-519-02-8) Price Trend of Key Raw Materials

    • 7.3 Sophocarpidine (CAS-519-02-8) Key Suppliers of Raw Materials

    • 7.4 Sophocarpidine (CAS-519-02-8) Market Concentration Rate of Raw Materials

    • 7.5 Sophocarpidine (CAS-519-02-8) Cost Structure Analysis

      • 7.5.1 Sophocarpidine (CAS-519-02-8) Raw Materials Analysis

      • 7.5.2 Sophocarpidine (CAS-519-02-8) Labor Cost Analysis

      • 7.5.3 Sophocarpidine (CAS-519-02-8) Manufacturing Expenses Analysis

    8 Global Sophocarpidine (CAS-519-02-8) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Sophocarpidine (CAS-519-02-8) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Sophocarpidine (CAS-519-02-8) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Sophocarpidine (CAS-519-02-8) Market Outlook by Types and Applications to 2022

    • 9.1 Global Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global High Purity Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Low Purity Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceuticals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pesticides Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Sophocarpidine (CAS-519-02-8) Market Analysis and Outlook till 2022

    • 10.1 Global Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.2.2 Canada Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.2.3 Mexico Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.2 UK Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.3 Spain Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.4 Belgium Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.5 France Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.6 Italy Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.7 Denmark Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.8 Finland Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.9 Norway Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.10 Sweden Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.11 Poland Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.12 Russia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.3.13 Turkey Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.2 Japan Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.3 India Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.4 South Korea Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.5 Pakistan Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.6 Bangladesh Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.7 Indonesia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.8 Thailand Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.9 Singapore Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.10 Malaysia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.11 Philippines Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.4.12 Vietnam Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.2 Colombia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.3 Chile Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.4 Argentina Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.5 Venezuela Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.6 Peru Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.5.8 Ecuador Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.6.2 Kuwait Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.6.3 Oman Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.6.4 Qatar Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.7.2 South Africa Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.7.3 Egypt Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.7.4 Algeria Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

      • 10.8.2 New Zealand Sophocarpidine (CAS-519-02-8) Consumption (2017-2022)

    11 Global Sophocarpidine (CAS-519-02-8) Competitive Analysis

    • 11.1 Indena

      • 11.1.1 Indena Company Details

      • 11.1.2 Indena Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Indena Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.1.4 Indena Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 TIANSHAN Pharmaceuticals

      • 11.2.1 TIANSHAN Pharmaceuticals Company Details

      • 11.2.2 TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.2.4 TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 QHL Pharma

      • 11.3.1 QHL Pharma Company Details

      • 11.3.2 QHL Pharma Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 QHL Pharma Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.3.4 QHL Pharma Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Tiansheng Pharmaceutical

      • 11.4.1 Tiansheng Pharmaceutical Company Details

      • 11.4.2 Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.4.4 Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Fujie Pharmaceutical

      • 11.5.1 Fujie Pharmaceutical Company Details

      • 11.5.2 Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.5.4 Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Jiangsu Tiansheng Pharmaceutical

      • 11.6.1 Jiangsu Tiansheng Pharmaceutical Company Details

      • 11.6.2 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.6.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Select Botanical

      • 11.7.1 Select Botanical Company Details

      • 11.7.2 Select Botanical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Select Botanical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.7.4 Select Botanical Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Selco Wirkstoffe Vertriebs GmbH

      • 11.8.1 Selco Wirkstoffe Vertriebs GmbH Company Details

      • 11.8.2 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.8.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Qinghai Lake Pharmaceuticals

      • 11.9.1 Qinghai Lake Pharmaceuticals Company Details

      • 11.9.2 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

      • 11.9.4 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Sophocarpidine (CAS-519-02-8) Market Outlook by Types and Applications to 2028

    • 12.1 Global Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global High Purity Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Low Purity Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pesticides Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Sophocarpidine (CAS-519-02-8) Market Analysis and Outlook to 2028

    • 13.1 Global Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.2 UK Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.5 France Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.3 India Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Sophocarpidine (CAS-519-02-8) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Sophocarpidine (CAS-519-02-8)

    • Figure of Sophocarpidine (CAS-519-02-8) Picture

    • Table Global Sophocarpidine (CAS-519-02-8) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Sophocarpidine (CAS-519-02-8) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global High Purity Consumption and Growth Rate (2017-2022)

    • Figure Global Low Purity Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Pesticides Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Table North America Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure United States Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Canada Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table Europe Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure Germany Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure UK Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Spain Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure France Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Italy Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Finland Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Norway Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Poland Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Russia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table APAC Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure China Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Japan Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure India Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table South America Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure Brazil Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Chile Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Peru Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table GCC Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure Bahrain Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Oman Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table Africa Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure Nigeria Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table Oceania Sophocarpidine (CAS-519-02-8) Consumption by Country (2017-2022)

    • Figure Australia Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Sophocarpidine (CAS-519-02-8) Consumption and Growth Rate (2017-2022)

    • Table Indena Company Details

    • Table Indena Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indena Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Indena Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table TIANSHAN Pharmaceuticals Company Details

    • Table TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table TIANSHAN Pharmaceuticals Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table QHL Pharma Company Details

    • Table QHL Pharma Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table QHL Pharma Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table QHL Pharma Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Tiansheng Pharmaceutical Company Details

    • Table Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Fujie Pharmaceutical Company Details

    • Table Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Fujie Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Jiangsu Tiansheng Pharmaceutical Company Details

    • Table Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Select Botanical Company Details

    • Table Select Botanical Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Select Botanical Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Select Botanical Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Selco Wirkstoffe Vertriebs GmbH Company Details

    • Table Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Table Qinghai Lake Pharmaceuticals Company Details

    • Table Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Main Business and Markets Served

    • Table Qinghai Lake Pharmaceuticals Sophocarpidine (CAS-519-02-8) Product Portfolio

    • Figure Global High Purity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Low Purity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pesticides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Table North America Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure United States Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure Germany Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure China Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Sophocarpidine (CAS-519-02-8) Consumption Forecast by Country (2022-2028)

    • Figure Australia Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Sophocarpidine (CAS-519-02-8) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US